Some prostate cancer cells even develop an androgen-repressed phenotype and cell culture and xenograft studies indicate that androgen treatment inhibits cancer cell proliferation via Skp1, c-Myc and p27 [29–31] in this setting. This evidence concerns the gene SKP1 and prostate carcinoma.